Das Ulcus cruris mixtum aus gefäßchirurgischer Sicht

Zusammenfassung

Bei der Therapie des in seiner Genese komplexen Ulcus cruris mixtum steht die Behandlung der arteriellen Durchblutungsstörung an erster Stelle. Sie schafft die Voraussetzung für die anschließende Sanierung des venösen Leidens. Hierfür ist die Kompressionstherapie von entscheidender Bedeutung. Chirurgische und konservative Maßnahmen zur Wundtherapie beeinflussen den Therapieverlauf in entscheidender Weise und helfen die Behandlungszeit zu verkürzen.

Abstract

In chronic leg ulcers in which the venous genesis is complicated by arterial disorders therapy is very complicated. First step should be the therapy of arterial occlusive disease. It is followed by therapy of the venous disease. Most important for that is compression therapy of the leg. Further the wound therapy is influenced and accelerated by surgical and conservative methods.

Literatur

• 1 Positionspapier der EWMA. Zum Verständnis der Kompressionstherapie. Medica Education Partnership Ltd. 2003
• 2 Wienert V. et al . S2 Leitlinie Intermittierende pneumatische Kompression (IPK oder AIK).  Phlebologie. 2005;  34 (3) 176-180
• 3 Creutzig A. et al . Meta-analysis of randomised controlled prostaglandin E1 studies in peripheral arterial occlusive disease stages III and IV.  Vasa. 2004;  33 (3) 137-144
• 4 Kwan C M. et al . The effect of intravenous infusion of prostaglandin E1 on cutaneous microcirculation in black foot disease.  J Formos Med Assoc. 1993;  92 (7) 603-608
• 5 Karl T. Ergebnisse der VAC Therapie in der Gefäßchirurgie.  Vasomed. 2004;  5 172-176
• 6 Hach W. Venenchirurgie. Stuttgart; Schattauer 2006
• 7 Hepp W, Kogel H. Gefäßchirurgie. München; Urban & Fischer 2001
• 8 Kudo T. et al . The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience.  J Vasc Surg. 2005;  41 (3) 423-435 [discussion 435]
• 9 Amato B. et al . Endovascular procedures in critical leg ischemia of elderly patients.  Acta Biomed. 2005;  76 (Suppl 1) 11-15
• 10 Mumcuoglu K Y. et al . Maggot therapy for the treatment of intractable wounds.  Int J Dermatol. 1999;  38 (8) 623-627
• 11 Nigam Y. et al . Maggot Therapy: The Science and Implication for CAM Part II-Maggots Combat Infection.  Evid Based Complement Alternat Med. 2006;  3 (3) 303-308 [Epub 2006 Jun 8]
• 12 Zoellner P. et al . A prospective, open-label study to assess the clinical performance of a foam dressing in the management of chronic wounds.  Ostomy Wound Manage. 2006;  52 (5) 34-36 [38, 40 – 42 passim]
• 13 Zoellner P. et al . Clinical performance of a hydrogel dressing in chronic wounds: a prospective observational study.  J Wound Care. 2007;  16 (3) 133-136
• 14 Fong J, Wood F. Nanocrystalline silver dressings in wound management: a review.  Int J Nanomedicine. 2006;  1 (4) 441-449
• 15 Norgren L, Hiatt W. et al . Inter- Society Consensus for Management of Peripheral Arterial Disease (TASC II).  Eur J Vasc Endovasc Surg. 2007;  33 (Suppl 1) 1-75
• 16 Peeters P. et al .Long term results with the Gore Propaten vascular graft in lower limb revascularisation: 3 year results. 30^th International Symposium of Charing Cross, Apr. 12 – 15, 2008 London. 
• 17 Battaglia G. et al . Retrospective comparison of a heparin bonded ePTFE graft and saphenous vein for infragenicular bypass: implications for standard treatment protocol.  J Cardiovasc Surg. 2006;  47 (1) 41-47